Aerie Pharmaceuticals, Inc. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ec3efb34-5079-471d-8c85-36dda9d87cbf/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-74.8M | 2021-01-01 – 2021-12-31 | evidence 0001337553-22-000013 |
| FY 2020 | $-183.1M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-003345 |
| FY 2019 | $-199.6M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002027 |
| FY 2018 | $-232.6M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-002369 |
| FY 2017 | $-145.1M | 2017-01-01 – 2017-12-31 | evidence 0001628280-18-002651 |
| FY 2016 | $-99.1M | 2016-01-01 – 2016-12-31 | evidence 0001628280-17-002421 |
| FY 2015 | $-74.4M | 2015-01-01 – 2015-12-31 | evidence 0001628280-16-012101 |
| FY 2014 | $-48.1M | 2014-01-01 – 2014-12-31 | evidence 0001628280-15-001188 |
| FY 2013 | $-101.6M | 2005-06-23 – 2014-03-31 | evidence 0001193125-14-197055 |
| FY 2012 | $-15.0M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-116752 |
| FY 2011 | $-13.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-116752 |
| FY 2010 | $-8.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-14-116752 |
| FY 2009 | $-8.0M | 2009-01-01 – 2009-12-31 | evidence 0001193125-14-116752 |
| FY 2008 | $-7.8M | 2008-01-01 – 2008-12-31 | evidence 0001193125-14-116752 |
| FY 2007 | $-6.7M | 2007-01-01 – 2007-12-31 | evidence 0001193125-14-116752 |
| FY 2006 | $-4.1M | 2006-01-01 – 2006-12-31 | evidence 0001193125-14-116752 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Aerie Pharmaceuticals, Inc. — all facts · Revenue · Operating Income